MXPA05004628A - Uso de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones del virus de influenza. - Google Patents
Uso de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones del virus de influenza.Info
- Publication number
- MXPA05004628A MXPA05004628A MXPA05004628A MXPA05004628A MXPA05004628A MX PA05004628 A MXPA05004628 A MX PA05004628A MX PA05004628 A MXPA05004628 A MX PA05004628A MX PA05004628 A MXPA05004628 A MX PA05004628A MX PA05004628 A MXPA05004628 A MX PA05004628A
- Authority
- MX
- Mexico
- Prior art keywords
- resveratrol
- virus
- cells
- infection
- viral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000562A ITRM20020562A1 (it) | 2002-11-06 | 2002-11-06 | Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza. |
| PCT/IT2003/000626 WO2004041260A1 (en) | 2002-11-06 | 2003-10-14 | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05004628A true MXPA05004628A (es) | 2005-09-08 |
Family
ID=32310188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05004628A MXPA05004628A (es) | 2002-11-06 | 2003-10-14 | Uso de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones del virus de influenza. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8431617B2 (enExample) |
| EP (1) | EP1567137B1 (enExample) |
| JP (1) | JP4589118B2 (enExample) |
| KR (1) | KR101060331B1 (enExample) |
| AR (1) | AR041891A1 (enExample) |
| AT (1) | ATE381929T1 (enExample) |
| AU (1) | AU2003279551A1 (enExample) |
| CA (1) | CA2504872C (enExample) |
| CY (1) | CY1107302T1 (enExample) |
| DE (1) | DE60318327T2 (enExample) |
| DK (1) | DK1567137T3 (enExample) |
| ES (1) | ES2295660T3 (enExample) |
| IT (1) | ITRM20020562A1 (enExample) |
| MX (1) | MXPA05004628A (enExample) |
| PL (1) | PL217628B1 (enExample) |
| PT (1) | PT1567137E (enExample) |
| TW (1) | TWI337863B (enExample) |
| WO (1) | WO2004041260A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2626056A1 (en) * | 2005-11-18 | 2007-05-24 | Ares Trading S.A. | Interferon in influenza |
| US8629283B2 (en) * | 2008-03-06 | 2014-01-14 | Icahn School Of Medicine At Mount Sinai | Compounds that modulate negative-sense, single-stranded RNA virus replication and uses thereof |
| AU2009313657A1 (en) * | 2008-11-04 | 2010-05-14 | Metaproteomics, Llc | Phytochemical compositions and methods for activating AMP-kinase |
| WO2010123527A2 (en) * | 2008-12-19 | 2010-10-28 | The Regents Of The University Of California | Use of epidermal growth factor inhibitors in the treatment of viral infection |
| KR100950445B1 (ko) | 2009-10-26 | 2010-04-02 | 주식회사 중앙백신연구소 | 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제 |
| US9096585B2 (en) | 2010-05-28 | 2015-08-04 | Icahn School Of Medicine At Mount Sinai | Antiviral compounds and uses thereof |
| US9453017B2 (en) * | 2011-09-30 | 2016-09-27 | Vanderbilt University | Antiviral therapies with phospholipase D inhibitors |
| PT2952209T (pt) | 2014-06-04 | 2018-05-09 | Alfasigma Spa | Formulações homogéneas compreendendo ácidos gordos poliinsaturados ómega-3 (n-3 pufa) e resveratrol para administração oral |
| SI2952180T1 (sl) | 2014-06-04 | 2017-05-31 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Trdne formulacije, ki vsebujejo resveratrol in polinenasičene maščobne kisline omega-3 (n-3 PUFA) |
| EP3120842A1 (en) * | 2015-07-20 | 2017-01-25 | Opterion Health AG | Peritoneal therapeutic fluid |
| KR20170039456A (ko) | 2015-10-01 | 2017-04-11 | 동아대학교 산학협력단 | 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물 |
| JP2018024592A (ja) * | 2016-08-09 | 2018-02-15 | 株式会社ブレインヘルス | 抗生物質含有組成物 |
| CN108893558B (zh) * | 2018-05-24 | 2022-04-05 | 江苏海宏制药有限公司 | 一种桑木液原液抗病毒实验方法以及装置 |
| EP4132277B1 (en) * | 2020-04-05 | 2025-11-26 | Mong, Michael | Systems and methods for treating coronavirus |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2778337B1 (fr) * | 1998-05-05 | 2001-08-31 | Inst Nat Sante Rech Med | Antagonistes des ligands du recepteur des arylhydrocarbures |
| PE20010540A1 (es) | 1999-07-30 | 2001-05-15 | Procter & Gamble | Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza |
| DE60015568D1 (de) * | 1999-08-13 | 2004-12-09 | Univ Maryland Biotech Inst | Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür |
-
2002
- 2002-11-06 IT IT000562A patent/ITRM20020562A1/it unknown
-
2003
- 2003-10-14 PL PL377557A patent/PL217628B1/pl unknown
- 2003-10-14 DK DK03772659T patent/DK1567137T3/da active
- 2003-10-14 DE DE60318327T patent/DE60318327T2/de not_active Expired - Lifetime
- 2003-10-14 CA CA2504872A patent/CA2504872C/en not_active Expired - Lifetime
- 2003-10-14 AT AT03772659T patent/ATE381929T1/de active
- 2003-10-14 KR KR1020057007230A patent/KR101060331B1/ko not_active Expired - Lifetime
- 2003-10-14 MX MXPA05004628A patent/MXPA05004628A/es active IP Right Grant
- 2003-10-14 US US10/533,942 patent/US8431617B2/en not_active Expired - Fee Related
- 2003-10-14 AU AU2003279551A patent/AU2003279551A1/en not_active Abandoned
- 2003-10-14 EP EP03772659A patent/EP1567137B1/en not_active Expired - Lifetime
- 2003-10-14 ES ES03772659T patent/ES2295660T3/es not_active Expired - Lifetime
- 2003-10-14 JP JP2004549541A patent/JP4589118B2/ja not_active Expired - Lifetime
- 2003-10-14 WO PCT/IT2003/000626 patent/WO2004041260A1/en not_active Ceased
- 2003-10-14 PT PT03772659T patent/PT1567137E/pt unknown
- 2003-10-27 TW TW092129780A patent/TWI337863B/zh not_active IP Right Cessation
- 2003-11-05 AR ARP030104047A patent/AR041891A1/es unknown
-
2008
- 2008-03-12 CY CY20081100281T patent/CY1107302T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4589118B2 (ja) | 2010-12-01 |
| DE60318327T2 (de) | 2008-12-18 |
| JP2006507295A (ja) | 2006-03-02 |
| AR041891A1 (es) | 2005-06-01 |
| PL377557A1 (pl) | 2006-02-06 |
| CA2504872A1 (en) | 2004-05-21 |
| PT1567137E (pt) | 2008-02-19 |
| TWI337863B (en) | 2011-03-01 |
| AU2003279551A1 (en) | 2004-06-07 |
| EP1567137B1 (en) | 2007-12-26 |
| EP1567137A1 (en) | 2005-08-31 |
| PL217628B1 (pl) | 2014-08-29 |
| TW200501935A (en) | 2005-01-16 |
| DK1567137T3 (da) | 2008-04-28 |
| WO2004041260A1 (en) | 2004-05-21 |
| ITRM20020562A1 (it) | 2004-05-07 |
| US20050239906A1 (en) | 2005-10-27 |
| US8431617B2 (en) | 2013-04-30 |
| CA2504872C (en) | 2011-07-05 |
| DE60318327D1 (de) | 2008-02-07 |
| ATE381929T1 (de) | 2008-01-15 |
| ES2295660T3 (es) | 2008-04-16 |
| KR101060331B1 (ko) | 2011-08-30 |
| CY1107302T1 (el) | 2012-11-21 |
| KR20050071627A (ko) | 2005-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yan et al. | Luteolin decreases the yield of influenza A virus in vitro by interfering with the coat protein I complex expression | |
| Mehrbod et al. | The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections | |
| RU2769317C2 (ru) | Способы лечения гриппа | |
| Amatore et al. | Influenza virus replication in lung epithelial cells depends on redox‐sensitive pathways activated by NOX4‐derived ROS | |
| Shin et al. | Broad‐spectrum antiviral effect of Agrimonia pilosa extract on influenza viruses | |
| MXPA05004628A (es) | Uso de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones del virus de influenza. | |
| Lu et al. | Peptidomimetic furin inhibitor MI-701 in combination with oseltamivir and ribavirin efficiently blocks propagation of highly pathogenic avian influenza viruses and delays high level oseltamivir resistance in MDCK cells | |
| EP4003322A1 (en) | Antioxidant and antiviral compositions and methods | |
| Zhu et al. | Inhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutinin | |
| Lackner et al. | N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro | |
| CN112316152B (zh) | 经酸酐修饰的蛋白质抑制冠状病毒的方法 | |
| Xu et al. | Inhibition of peptide BF-30 on influenza A virus infection in vitro/vivo by causing virion membrane fusion | |
| Khanna et al. | Thiol drugs decrease SARS-CoV-2 lung injury in vivo and disrupt SARS-CoV-2 spike complex binding to ACE2 in vitro | |
| EP1447083A1 (en) | Preventives/remedies for viral infection | |
| Yang et al. | Exploration of the mechanisms of Callicarpa nudiflora Hook. et Arn against influenza A virus (H1N1) infection | |
| Makarevich et al. | Anti-influenza activity of Cetraria islandica lichen extracts in in vitro experiments | |
| García et al. | Characterization of Junín virus particles inactivated by a zinc finger-reactive compound | |
| Lozitsky | Anti-infectious actions of proteolysis inhibitor ε-aminocaproic acid (ε-ACA) | |
| CN119868562B (zh) | Cul4b激活剂在制备抗流感病毒药物中的应用 | |
| RU2695336C1 (ru) | Композиция на основе пептида, подавляющего репликацию вируса гриппа А | |
| Pérot | Deciphering the impact of macroautophagy perturbation by influenza A virus on virus replication and host cell response to infection | |
| CN115243712A (zh) | 膜抑制剂在促进针对包膜病毒的疫苗的开发中的用途 | |
| Goulding | Calcium dependent host innate immune resistance to influenza A virus infection | |
| CN116531509A (zh) | 一种基于天然萘醌的药物组合物及应用 | |
| Chamberlain | Pathological Consequences Of Pdi Oxidoreductase Activity On Viral Protein Maturation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |